Ketamine's antidepressant effect: Focus on ketamine mechanisms of action

被引:9
作者
De Maricourt, P. [1 ,2 ]
Jay, T. [2 ]
Goncalves, P. [3 ]
Loo, H. [1 ]
Gaillard, R. [1 ,2 ]
机构
[1] Univ Paris 05, Hop St Anne, Ctr Hosp St Anne, Serv Hosp Univ Sante Mentale & Therapeut, F-75014 Paris, France
[2] Univ Paris 05, INSERM, UMR 894, Ctr Psychiat & Neurosci,Sorbonne Paris Cite, F-75014 Paris, France
[3] 93G11 EPS Ville Evrard, Clin Bois Bondy, F-93140 Bondy, France
来源
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 2014年 / 40卷 / 01期
关键词
Glutamate; Ketamine; Major depressive disorder; NMDA receptors; Treatment-resistant depression; NMDA RECEPTOR BLOCKADE; GLYCOGEN-SYNTHASE KINASE-3; D-ASPARTATE ANTAGONIST; ALLOSTERIC MODULATOR; MAMMALIAN TARGET; RANDOMIZED-TRIAL; GLUTAMATE; DEPRESSION; PAIN; ACID;
D O I
10.1016/j.encep.2013.09.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background. - In recent years, discovery of ketamine's fast and powerful antidepressant effects for treatment-resistant depression (TRD) has led to rethinking of the pathophysiology of depression. Numerous studies in humans and animals have focused on mechanisms of action underlying this effect, producing a number of explanatory pathways. Method. - The aim of this article is to summarize the various hypotheses underlying rapid antidepressant action of ketamine and therefore to better understand the mechanisms underlying depression and antidepressant action. Results. - Ketamine unique antidepressant properties have led to many studies on its neurobiological grounds. Intracellular signaling pathways such as mTOR, GSK3 or eEF2 seem to play a key role and are associated with an increased synaptic plasticity. Other hypotheses are discussed such as ketamine effects on neuro-inflammation, the role of anterior cingulate cortex in brain changes induced by ketamine, and the potential benefits of analgesic properties of ketamine in depressive disorders. Conclusion. - Our review highlights the potential role of the glutamatergic system in the pathophysiology and treatment of mood disorders. Understanding which pathways underlie the fast antidepressant effect of ketamine paves the way for the development of new antidepressants. (C) L'Encephale, Paris, 2013.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 83 条
  • [1] Ketamine for Depression: Where Do We Go from Here?
    Aan Het Rot, Marije
    Zarate, Carlos A., Jr.
    Charney, Dennis S.
    Mathew, Sanjay J.
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 72 (07) : 537 - 547
  • [2] A role for AMPA receptors in mood disorders
    Alt, A
    Nisenbaum, ES
    Bleakman, D
    Witkin, JM
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 71 (09) : 1273 - 1288
  • [3] [Anonymous], MOL PSYCHIAT
  • [4] [Anonymous], GLOB BURD DIS 2004 U
  • [5] NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
    Autry, Anita E.
    Adachi, Megunai
    Nosyreva, Elena
    Na, Elisa S.
    Los, Maarten F.
    Cheng, Peng-fei
    Kavalali, Ege T.
    Monteggia, Lisa M.
    [J]. NATURE, 2011, 475 (7354) : 91 - U109
  • [6] Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder:: A pilot study
    Bares, Martin
    Brunovsky, Martin
    Kopecek, Miloslav
    Stopkova, Pavla
    Novak, Tomas
    Kozeny, Jiri
    Hoschl, Cyril
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2007, 41 (3-4) : 319 - 325
  • [7] Ketamine for chronic non-cancer pain
    Bell, Rae Frances
    [J]. PAIN, 2009, 141 (03) : 210 - 214
  • [8] Bergman S A, 1999, Anesth Prog, V46, P10
  • [9] Antidepressant effects of ketamine in depressed patients
    Berman, RM
    Cappiello, A
    Anand, A
    Oren, DA
    Heninger, GR
    Charney, DS
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 351 - 354
  • [10] Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
    Beurel, E.
    Song, L.
    Jope, R. S.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (11) : 1068 - 1070